Deborah L Keller's Net Worth

$14.9 Million

Estimate Recalculated Jun 13, 2024 03:49PM EST

Who is Deborah L Keller?

Deborah L Keller has an estimated net worth of $14.9 Million. This is based on reported shares across multiple companies, which include WEST PHARMACEUTICAL SERVICES INC, LABORATORY CORP OF AMERICA HOLDINGS, and COVANCE INC.

SEC CIK

Deborah L Keller's CIK is 0001352992

Past Insider Trading and Trends

2014 was Deborah L Keller's most active year for acquiring shares with 7 total transactions. Deborah L Keller's most active month to acquire stocks was the month of January. 2014 was Deborah L Keller's most active year for disposing of shares, totalling 9 transactions. Deborah L Keller's most active month to dispose stocks was the month of January. 2014 saw Deborah L Keller paying a total of $1,870,810.00 for 56,260 shares, this is the most they've acquired in one year. In 2015 Deborah L Keller cashed out on 112,565 shares for a total of $2,214,038.15, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

WEST PHARMACEUTICAL SERVICES INC (WST) Snapshot price: $412.81

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+6.25%
564
—
—
9.59K
Apr 23
Form 4
+7.33%
616
—
—
9.02K
Apr 25
Form 4
+8.13%
632
—
—
8.41K
May 24
Form 4
+8.02%
577
—
—
7.77K
May 4
Form 4
+15.71%
975
—
—
7.18K
May 5
Form 4
+47.20%
1.56K
—
—
4.88K
May 7
Form 4
—
0
—
—
0
Dec 31
Form 4
—
0
—
—
0
Sep 28
Form 4
—
0
—
—
0
Dec 29 - Jun 29
Form 4
+122.81%
1.82K
—
—
3.31K
May 1
Form 4
—
0
—
—
0
Sep 29
Form 4
—
0
—
—
0
Jun 30
Form 4
∞
1.48K
—
—
1.48K
Jun 1
Form 3
—
0
—
—
0
No matching records found

LABORATORY CORP OF AMERICA HOLDINGS (LH) Snapshot price: $223.55

CEO, Covance Drug Development

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+73.11%
8.34K
$115.49
-$529,752.63
19.75K
Mar 11
Form 4
—
0
—
—
0
Feb 9
Form 3
—
0
—
—
0
No matching records found

COVANCE INC No price found

Corp. Executive Vice President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-58.95K
$107.19
—
0
Feb 19
Form 4
-5.89%
-3.69K
$102.61
-$378,836.12
58.95K
Dec 17
Form 4
+7.24%
4.23K
$84.04
-$403,614.98
62.65K
Dec 5
Form 4
+23.19%
11K
$101.95
-$47,202.85
58.42K
Feb 18
Form 4
-6.07%
-3.06K
$68.97
-$948,373.10
47.42K
Feb 7
Form 4
-4.80%
-2.54K
$84.31
-$214,568.95
50.48K
Dec 17
Form 4
-2.21%
-1.20K
$69.79
-$491,592.00
53.03K
Aug 21
Form 4
+23.72%
10.4K
$69.01
-$10,489.52
54.23K
Feb 19
Form 4
-3.29%
-1.49K
$58.86
-$87,760.26
43.83K
Dec 18
Form 4
-6.13%
-2.96K
$54.55
-$161,577.10
45.32K
Nov 16
Form 4
+35.97%
12.77K
$48.16
-$5,875.52
48.28K
Feb 20
Form 4
-3.65%
-1.34K
$44.59
-$59,928.96
35.51K
Dec 19
Form 4
-17.13%
-7.62K
$41.78
-$513,403.86
36.85K
Mar 31
Form 4
+96.43%
21.77K
$58.37
-$4,494.49
44.35K
Feb 17
Form 4
-3.28%
-766.00
—
—
22.58K
Dec 20
Form 4
-100.00%
-956.00
$54.37
-$51,977.72
0
Jun 22
Form 4
+11.62%
2.21K
—
—
21.2K
Feb 16 - Feb 17
Form 4
-10.69%
-2.27K
$51.18
-$116,280.96
18.99K
Dec 18
Form 4
+35.94%
5.62K
$39.80
-$12,576.80
21.26K
Feb 19
Form 4
-18.17%
-3.47K
$41.00
-$142,393.00
15.64K
Dec 19
Form 4
—
0
$69.35
-$195,199.74
19.11K
Aug 28
Form 4
+32.66%
4.67K
—
—
18.98K
Feb 21
Form 4
—
0
$49.15
-$157,167.00
14.19K
Sep 11
Form 4
+139.82%
8.02K
—
—
13.76K
Feb 22
Form 3
—
0
—
—
0
No matching records found